Long-term converting-enzyme inhibition as a guide to surgical curability of hypertension associated with renovascular disease
- 1 May 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (8) , 1317-1322
- https://doi.org/10.1016/0002-9149(83)90305-3
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Captopril in the management of hypertension with renal artery stenosis: Its long-term effect as a predictor of surgical outcomeThe American Journal of Cardiology, 1982
- Captopril in renovascular hypertension: long-term use in predicting surgical outcome.BMJ, 1982
- Reactive Hyperreninemia in Renovascular Hypertension After Angiotensin Blockade with Saralasin or Converting Enzyme InhibitorAnnals of Internal Medicine, 1979
- Radioimmunoassay of angiotensin II in unextracted plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Detection of Renovascular Hypertension with Angiotensin II BlockadeAnnals of Internal Medicine, 1977
- Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patientsThe American Journal of Medicine, 1976
- Methodological simplifications in radioimmunoassay of urinary aldosteroneClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” HypertensionNew England Journal of Medicine, 1975
- Renovascular hypertension: Renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curabilityThe American Journal of Medicine, 1973
- Antihypertensive action of propranolol: Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertensionThe American Journal of Cardiology, 1973